Appendectomy can reduce the risk of Parkinson's disease

  In a new study, researchers in the United States, France, Sweden and Canada report that cavumectomy can reduce the risk of Parkinson's disease. They determined the connection between this surgical method and this neurodegenerative disease from the health data of 1.6 million Swedes.

  When using this data set to analyze the appendage tissue of healthy people, these researchers found that the appendage tissue contains a large amount of protein, similar to the protein observed in the brain of Parkinson's disease patients. done. This finding suggests that the appendix plays a role in the early stages of the disease through the accumulation of this same protein. Because these proteins cause Parkinson's disease in some way, epithelial resection may prevent its harmful activity. PerBorghammer, a neuroscientist at Ahus University in Denmark, said: "This is related to whether Parkinson's disease is due to the entire intestinal prosperous region. This is why we are dealing with this disease.

  The corresponding author of the paper, Viviane Labrie, an assistant professor at the Winandel Institute in the United States, said that this disease is a multi-family disease. "So, from the beginning of the disease, Parkinson's disease may have many causes.] One of them. For other causes, it can occur in the brain."

  Compared with the brain and because the symptoms of this disease may appear in the early intestines, in order to understand the reason, Labri and her colleagues were once considered useless, but now they are scanning for infectious pathogens. I studied an appendix that plays a role in the immune system. The health data of this group of Swedes shows that if people undergo trichomectomy, their risk of Parkinson's disease will be reduced by 19%. In another test, the researchers found that out of 48 appendage tissue samples from healthy individuals, 46 samples had large amounts of α-n-octane. This protein is found in the brains of Parkinson's disease patients.

  Lovely said: "We are not going to perform wormectomy." She said, on the contrary, she hopes that this research can help scientists better understand why αsinucrane is not successfully synthesized and why it accumulates in the intestines and brain.